Literature DB >> 23147038

Streptococcus pneumoniae capsular serotype invasiveness correlates with the degree of factor H binding and opsonization with C3b/iC3b.

Catherine Hyams1, Krzysztof Trzcinski, Emilie Camberlein, Daniel M Weinberger, Suneeta Chimalapati, Mahdad Noursadeghi, Marc Lipsitch, Jeremy S Brown.   

Abstract

Different capsular serotypes of Streptococcus pneumoniae vary markedly in their ability to cause invasive infection, but the reasons why are not known. As immunity to S. pneumoniae infection is highly complement dependent, variations in sensitivity to complement between S. pneumoniae capsular serotypes could affect invasiveness. We have used 20 capsule-switched variants of strain TIGR4 to investigate whether differences in the binding of the alternative pathway inhibitor factor H (FH) could be one mechanism causing variations in complement resistance and invasive potential between capsular serotypes. Flow cytometry assays were used to assess complement factor binding and complement-dependent neutrophil association for the TIGR4 capsule-switched strains. FH binding varied with the serotype and inversely correlated with the results of factor B binding, C3b/iC3b deposition, and neutrophil association. Differences between strains in FH binding were lost when assays were repeated with pspC mutant strains, and loss of PspC also reduced differences in C3b/iC3b deposition between strains. Median FH binding was high in capsule-switched mutant strains expressing more invasive serotypes, and a principal component analysis demonstrated a strong correlation between serotype invasiveness, high FH binding, and resistance to complement and neutrophil association. Further data obtained with 33 clinical strains also demonstrated that FH binding negatively correlated with C3b/iC3b deposition and that median FH binding was high in strains expressing more invasive serotypes. These data suggest that variations in complement resistance between S. pneumoniae strains and the association of a serotype with invasiveness could be related to capsular serotype effects on FH binding.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23147038      PMCID: PMC3536142          DOI: 10.1128/IAI.00862-12

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice.

Authors:  Jeremy S Brown; Tracy Hussell; Sarah M Gilliland; David W Holden; James C Paton; Michael R Ehrenstein; Mark J Walport; Marina Botto
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-11       Impact factor: 11.205

2.  Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production.

Authors:  M K Hostetter
Journal:  J Infect Dis       Date:  1986-04       Impact factor: 5.226

3.  Streptococcus pneumoniae recruits complement factor H through the amino terminus of CbpA.

Authors:  Ling Lu; Yueyun Ma; Jing-Ren Zhang
Journal:  J Biol Chem       Date:  2006-04-05       Impact factor: 5.157

Review 4.  Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis.

Authors:  Daniel M Weinberger; Zitta B Harboe; Elisabeth A M Sanders; Moses Ndiritu; Keith P Klugman; Simon Rückinger; Ron Dagan; Richard Adegbola; Felicity Cutts; Hope L Johnson; Katherine L O'Brien; J Anthony Scott; Marc Lipsitch
Journal:  Clin Infect Dis       Date:  2010-09-15       Impact factor: 9.079

5.  Human neutrophils kill Streptococcus pneumoniae via serine proteases.

Authors:  Alistair J Standish; Jeffrey N Weiser
Journal:  J Immunol       Date:  2009-07-20       Impact factor: 5.422

6.  The role of complement in innate and adaptive immunity to pneumococcal colonization and sepsis in a murine model.

Authors:  D Bogaert; C M Thompson; K Trzcinski; R Malley; M Lipsitch
Journal:  Vaccine       Date:  2009-11-03       Impact factor: 3.641

7.  Pattern of accessory regions and invasive disease potential in Streptococcus pneumoniae.

Authors:  C Blomberg; J Dagerhamn; S Dahlberg; S Browall; J Fernebro; B Albiger; E Morfeldt; S Normark; B Henriques-Normark
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

8.  Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease.

Authors:  Inci Yildirim; William P Hanage; Marc Lipsitch; Kimberly M Shea; Abbie Stevenson; Jonathan Finkelstein; Susan S Huang; Grace M Lee; Ken Kleinman; S I Pelton
Journal:  Vaccine       Date:  2010-10-26       Impact factor: 3.641

9.  Changes in capsular serotype alter the surface exposure of pneumococcal adhesins and impact virulence.

Authors:  Carlos J Sanchez; Cecilia A Hinojosa; Pooja Shivshankar; Catherine Hyams; Emilie Camberlein; Jeremy S Brown; Carlos J Orihuela
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

10.  Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes.

Authors:  Stephen D Bentley; David M Aanensen; Angeliki Mavroidi; David Saunders; Ester Rabbinowitsch; Matthew Collins; Kathy Donohoe; David Harris; Lee Murphy; Michael A Quail; Gabby Samuel; Ian C Skovsted; Margit Staum Kaltoft; Bart Barrell; Peter R Reeves; Julian Parkhill; Brian G Spratt
Journal:  PLoS Genet       Date:  2006-03-10       Impact factor: 5.917

View more
  46 in total

1.  Low invasiveness of pneumococcal serotype 11A is linked to ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation.

Authors:  Allison M Brady; Juan J Calix; Jigui Yu; Kimball Aaron Geno; Gary R Cutter; Moon H Nahm
Journal:  J Infect Dis       Date:  2014-03-27       Impact factor: 5.226

Review 2.  Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion.

Authors:  Samantha J Dando; Alan Mackay-Sim; Robert Norton; Bart J Currie; James A St John; Jenny A K Ekberg; Michael Batzloff; Glen C Ulett; Ifor R Beacham
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

3.  Antibody-mediated complement C3b/iC3b binding to group B Streptococcus in paired mother and baby serum samples in a refugee population on the Thailand-Myanmar border.

Authors:  Jenny Herbert; Stephen Thomas; Charlotte Brookes; Claudia Turner; Paul Turner; Francois Nosten; Kirsty Le Doare; Michael Hudson; Paul T Heath; Andrew Gorringe; Stephen Taylor
Journal:  Clin Vaccine Immunol       Date:  2015-01-14

Review 4.  Streptococcus pneumoniae: transmission, colonization and invasion.

Authors:  Jeffrey N Weiser; Daniela M Ferreira; James C Paton
Journal:  Nat Rev Microbiol       Date:  2018-06       Impact factor: 60.633

Review 5.  Models of immune selection for multi-locus antigenic diversity of pathogens.

Authors:  Maria Georgieva; Caroline O Buckee; Marc Lipsitch
Journal:  Nat Rev Immunol       Date:  2019-01       Impact factor: 53.106

6.  CovR Regulates Streptococcus mutans Susceptibility To Complement Immunity and Survival in Blood.

Authors:  Lívia A Alves; Ryota Nomura; Flávia S Mariano; Erika N Harth-Chu; Rafael N Stipp; Kazuhiko Nakano; Renata O Mattos-Graner
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

7.  Position of O-Acetylation within the Capsular Repeat Unit Impacts the Biological Properties of Pneumococcal Serotypes 33A and 33F.

Authors:  Brady L Spencer; Jamil S Saad; Anukul T Shenoy; Carlos J Orihuela; Moon H Nahm
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

8.  Streptococcus pneumoniae PspC Subgroup Prevalence in Invasive Disease and Differences in Contribution to Complement Evasion.

Authors:  Erika van der Maten; Bryan van den Broek; Marien I de Jonge; Kim J W Rensen; Marc J Eleveld; Aldert L Zomer; Amelieke J H Cremers; Gerben Ferwerda; Ronald de Groot; Jeroen D Langereis; Michiel van der Flier
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

9.  Relating Pneumococcal Carriage Among Children to Disease Rates Among Adults Before and After the Introduction of Conjugate Vaccines.

Authors:  Daniel M Weinberger; Lindsay R Grant; Robert C Weatherholtz; Joshua L Warren; Katherine L O'Brien; Laura L Hammitt
Journal:  Am J Epidemiol       Date:  2016-05-02       Impact factor: 4.897

10.  Discovery of Streptococcus pneumoniae serotype 6 variants with glycosyltransferases synthesizing two differing repeating units.

Authors:  Melissa B Oliver; Mark P G van der Linden; Sharon A Küntzel; Jamil S Saad; Moon H Nahm
Journal:  J Biol Chem       Date:  2013-07-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.